BOULE DIAGNOSTICS AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.3 SEK | +0.49% |
|
+3.00% | -8.20% |
| May. 08 | Boule Diagnostics AB Appoints Rikke Rytter as Director | CI |
| May. 07 | Transcript : Boule Diagnostics AB, Q1 2024 Earnings Call, May 07, 2024 |
Presenter SpeechJesper Söderqvist (Executives)Welcome. This is Jesper Söderqvist. I am the CEO...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Companyâs product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Companyâs primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Calendar
2024-07-22
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
10.25
SEK
Average target price
10.9
SEK
Spread / Average Target
+6.34%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -8.20% | 36.79M | |
| +12.85% | 227B | |
| +13.88% | 192B | |
| +18.39% | 136B | |
| +28.78% | 108B | |
| +1.67% | 64.07B | |
| +18.24% | 52.1B | |
| +7.04% | 51.87B | |
| +10.83% | 44.33B | |
| +5.94% | 36.75B |
- Stock Market
- Equities
- BOUL Stock
- News Boule Diagnostics AB
- Transcript : Boule Diagnostics AB, 2020 Earnings Call, Feb 03, 2021
